Brief: Argent Biopharma Enters Collaboration Agreement For Argent EU GMP Facility In Malta
09/04/2025 24:12
April 9 (Reuters) - Argent BioPharma Ltd RGT.AX: STRATEGIC COLLABORATION AGREEMENT FOR ARGENT EU GMP FACILITY IN MALTA STRATEGIC COLLABORATION GRANTING DAVID TRADING EXCLUSIVE RIGHTS TO OPERATE RGT'S FACILITY IN MALTA DAVID TRADING GRANTED EXCLUSIVE, IRREVOCABLE OPTION TO ACQUIRE 100% OF FACILITY COMPANY'S SHARES Further company coverage: RGT.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group